CBD for Arthritis

Understanding Arthritis

Arthritis is a medical condition characterized by pain and inflammation in one or more joints [1]. The most common types of arthritis are osteoarthritis and rheumatoid arthritis. Osteoarthritis is caused by a loss of smooth cartilage in the lining of a joint, which can lead to movement problems, pain, swelling, and the formation of bony spurs called osteophytes. In severe cases, the loss of cartilage can cause bones to rub against each other, leading to joint dislocation.

Rheumatoid arthritis, on the other hand, occurs when the body’s immune system targets the affected joints, causing pain and swelling. This inflammation can spread to the entire joint, leading to further swelling and, in some cases, a change in the joint’s shape. The cartilage may also break down as a result of this inflammation.

It’s important to note that while osteoarthritis and rheumatoid arthritis are the most prevalent forms of arthritis, there are over 100 other types, each with unique symptoms and causes. Although some treatments may be effective across multiple types of arthritis, what works for one individual may not work for another. Additionally, individuals who are already taking medication for arthritis should check with their doctor before adding CBD to their regimen, as there is a possibility of interaction between the two.

Research on CBD

CBD has gained popularity in recent years for its potential therapeutic benefits in various health conditions, including arthritis. Although research on the effects of CBD on specific conditions is still ongoing, completed studies [2 have demonstrated positive results.

According to an article [3], CBD has demonstrated anti-inflammatory effects in multiple inflammatory conditions, including arthritis, and possesses anti-arthritic activity. Similarly, a study [4] found that CBD gel significantly reduced joint swelling and showed therapeutic potential for relieving the pain and inflammation associated with arthritis without evident side effects.

In addition, an anonymous questionnaire of participants with arthritis showed that 83% reported improvements in pain, 66% reported better physical function, and 66% reported better sleep quality with CBD use [5]. The majority of respondents reported a reduction or complete stop of other medications after CBD use. Furthermore, the study found a greater percentage reduction and point reduction with osteoarthritis than with rheumatoid arthritis and other autoimmune arthritis.

It is important to note that while CBD has shown promise in helping with arthritis, there are over 100 types of arthritis that interact differently with the body. Therefore, it is crucial to consult with a healthcare professional before using CBD as it may interact with other medications.

CBD Benefits

CBD has gained popularity as an alternative medication for arthritis due to the risks associated with traditional arthritis medications. Acetaminophen, commonly used to treat arthritis, is generally safe but can cause liver damage and does not reduce inflammation, a key trigger of pain [6]. Nonsteroidal anti-inflammatory drugs (NSAIDs) effectively reduce inflammation, but can lead to adverse side effects such as kidney damage and bleeding in the digestive system, especially in older populations. Opioid medication, while attempting to mask the pain, can lead to physical dependence and addiction, and long-term use can cause serious health risks, including accidental overdose death, especially for those aged 45-54, a demographic with a high incidence rate of arthritis. As 50% of arthritis patients are over 65, the adverse effects of traditional medications can pose a serious health risk to older patients.

References

1. https://www.nhs.uk/conditions/arthritis/
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561449/
3. https://www.nature.com/articles/s41419-020-02892-1
4. https://onlinelibrary.wiley.com/doi/abs/10.1002/ejp.818
5. https://link.springer.com/article/10.1186/s42238-022-00154-9
6. https://athmjournal.com/beyondcbd/wp-content/uploads/sites/3/2020/02/Khaleghi.pdf